No. 117 (April 2019)
unsubscribe
Regular sections:
Hot topics:

REGISTER
to access members-only pages on the APSR website
.

APSR News

Air Pollution

A joint APSR/ATS perspective of air pollution in the Asia-Pacific region


(Click image to enlarge)

Read this recently published APSR-ATS perspective, the first joint-society publication (in the AJRCCM and Respirology).

Experts from the US, Hong Kong, Republic of Korea, Japan, China and Australia have worked together to bring you:

Air Pollution in the Asia-Pacific Region. A Joint Asian Pacific Society of Respirology/American Thoracic Society Perspective
Crystal M North, Mary B Rice, Thomas Ferkol, David Gozal, Christopher Hui, Soon-Hee Jung, Kozo Kuribayashi, Meredith C McCormack, Michiaki Mishima, Yasuo Morimoto, Yuanlin Song, Kevin C Wilson, Woo Jin Kim, Kwun M Fong
onlinelibrary.wiley.com/doi/10.1111/resp.13531

We hope to bring you results of further APSR assembly collaboration activities with our sister societies in the future.

2019 Congress banner

Congress news

Vietnam 2019

Abstracts are now being accepted for the 2019 Congress to be held in Hanoi, Vietnam, 14-17 November 2019:

A couple of months ago in Vietnam, Google proudly reminded us that 2019 is the Year of the Pig.

For those who believe that the zodiac has any meaning, the pig represents "Communication and Friendship".

So there couldn't be a better year to declare that 2019 in Vietnam is also the Year of the APSR Congress!

Keep checking apsr2019.com regularly for updates.

Get two birds with one stone!

i.e. Get two registrations for the price of one bird!

Volunteer to live-tweet and upload to the APSR's social networking accounts during the ATS International Conference 2019 in Dallas and get a free registration for the APSR Congress 2019 in Hanoi.

We are looking for a volunteer to contribute to the APSR's Twitter, Facebook and Instagram accounts; in particular, APSR-related activities at the Conference.

This is an open invitation for any young APSR member who is attending the ATS International Conference to apply. The successful applicant will have excellent SNS skills, and plans to attend all (or most) of the ATS International Conference from 17–May 2019.

Preference will be given to those aged ≤ 30.

The successful volunteer will be offered complimentary registration for the APSR Congress in Hanoi, November 2019. He or she will be required to contact the APSR Secretariat staff each day to agree the next day's schedule and receive any special instructions, and provide around 10–20 tweets and uploads each day to the APSR's Twitter, Facebook and Instagram accounts. Examples of items of interest include the:

  • opening ceremony
  • major sessions
  • APSR young investigator sessions
  • APSR-ISRD joint session on 18 May
  • notices from the APSR booth
  • notices from the venue
  • etc.

To apply for this opportunity, please submit to Ms Kishigami at the APSR Secretariat rina.kishigami@theapsr.org:

  • a brief (one page) curriculum vitae
  • the dates you plan to attend the Conference
  • your Twitter, Facebook and Instagram accounts for the APSR Secretariat to see your past tweets and uploads

Application deadline:

  • 25 April 2019

Contact the APSR Secretariat APSR@theapsr.org if you have any queries.

We are looking forward to working with you!

Travel Award opportunities

The January 2019 issue of the APSR Newsletter includes glowing reports from last year's award winners.

Enjoy similar rewards yourself by taking advantage of the following opportunities:

*"LMIC" is defined as a "lower-middle income country", a list of which can be seen at data.worldbank.org/income-level/low-and-middle-income.

Our Members, Our Future

Continuing this series we are delighted to share a tribute to Prof. Yoshinosuke Fukuchi, prepared by Prof. Michiaki Mishima.

This series complements our APSR Members' Honour Roll, on which as a member, you are welcome to add your appreciation of your mentor(s) at any time.


Prof. Fukuchi

A tribute to Yoshinosuke Fukuchi MD PhD
Professor Emeritus Juntendo University Tokyo Japan

Lifelong commitment in research and promotion of respirology

Dr Yoshinosuke Fukuchi graduated from Department of Medicine, Gunma University in 1964, After completing an internship/medical residency at US Air Force Hospital in Tachikawa, Tokyo, he started his early training at Department of Geriatrics, the University of Tokyo Japan in 1966. Under warm but stringent mentorship of Professor Michiyoshi Harasawa, he was awarded a Ph.D. for an experimental study aiming at age effects on bronchial circulation in 1972. He spent a two-year research/clinical fellowship at Meakins-Christie Laboratories (MCL), McGill University, Montreal, Canada in 1974-1976. The MCL was a highly reputed centre for cutting-edge research in pulmonary physiology under the directorship of Professor Peter T Macklem. MCL enabled him to make lasting friendship with many distinguished investigators including Professor Ann J Woolcock. Among nine research papers published during those years, the most notable was a novel finding of cardiogenic oscillation facilitating intrapulmonary diffusive mixing (CGM). CGM may have heralded later development of high frequency ventilation.

He stayed at Tokyo University serving as senior lecture (1979) and associate professor (1986) for 30 years. He was among the first to point out the importance of accelerated aging in the pathogenesis of COPD through physio-chemical studies in Senescent Accelerated Mouse (SAM) around 1990 to 2000. He took the chair of the department of respiratory medicine at Juntendo University in 1996. His research interest in animal model of COPD (SAM and SMP-30 KO) was relentlessly maintained and produced significant papers through his tenure at Juntendo University.

He worked hard always with 4D (Diligence, Dedication, Diversity, Decision) in mind, as principles to fulfill the mission of the chairmanship. We witnessed the department attracting many young doctors who completed successful clinical as well as academic training.

Since the early days of his career the promotion of respiratory science, both in Japan and Asia-Pacific countries, became the priority in addition to his own research interest. This wish grew further when he was appointed Chairman of the International Relations Committee (IRC) of the Japanese Respiratory Society (JRS). In close collaboration with Professors Yoshihiro Hayata, Shiro Kira and J Patrick Barron, IRC could convince the Board of Directors of the JRS to move forward to launch an academic society in the Asia-Pacific region to promote respiratory science and clinical practice toward higher quality. The JRS held an international respiratory conference in Tokyo, 1985. An international panel of distinguished clinician scientists representing the Asia-Pacific region, North/South America and Europe, were called upon to discuss the need and feasibility of such venture in this region. All delegates agreed upon the momentum to step forward to formulate an independent academic society in the Asia-Pacific region. Whenever asked, he recalled an enormous zeal and sagacious advice by which Professor Ann J Woolcock suggested a list of eminent academicians in the Asia-Pacific region to be invited. All the listed delegates in fact made core members of a steering committee of the proposed society. In 1986 the society was officially established under the name of the Asian Pacific Society of Respirology (APSR) during the IUATLD congress in Singapore.

It was decided that a biannual congress was to be organized and the first Congress was held in Tokyo with Professor Michiyoshi Harasawa as presiding president in 1988. The JRS fully supported this congress together with participating member country societies with a great success. This outcome paved a road towards further progress for the APSR. The APSR Secretariat was located in the department of geriatrics in the early days after the launch and he assisted Professor Shiro Kira in business communications with his personal secretary.

In 1996, Respirology was published as the official journal of the Society every 6 months when the Secretariat relocated to a new office in Hongo, Tokyo. Due to the limited membership size and marginal financial income from the congress, it was hard to maintain regular publication of the journal. He, together with Professor J Patrick Barron, managed to overcome this financial difficulty by printing extended abstracts for additional donation to supplement the deficit.

He organized the 41st JRS annual congress in Tokyo and introduced its International Programme in English to meet the mounting need for globalization of the Society's activities. He offered an occasion for delegates from the APSR, ATS, ERS, IUATLAD and ALAT to meet face to face for the first time. This meeting was highly appreciated among global leaders and stimulated later development of Forum of International Respiratory Societies (FIRS).

In 2003, as Chairman of the JRS Board of Directors (BOD) he played a pivotal role in convincing the Board to apply for en bloc membership of the APSR. This was a novel system of securing large number of members on regular basis which gave the APSR greater financial stability thereafter.

His 4D principles has helped him to achieve a productive life and accomplish what he aimed at in his youth.


Prof. Mishima
Prepared by Michiaki Mishima, M.D./Ph.D.
Past President, APSR
President, Osaka Saiseikai Noe Medical Welfare Center, Japan
President, Osaka Saiseikai Noe Hospital, Japan
Emeritus Professor, Kyoto University, Japan

Professor Mishima highly appreciates that Professor Fukuchi has been a great mentor and a mariner's compass of his life in the past 40 years.

March 2019

Respiratory Updates

The March issue (Vol 11.3) features Invited review series: Tuberculosis update 2018:

  • Tuberculosis updates 2018: Innovations and developments to end TB
  • Tuberculosis vaccines: Opportunities and challenges
  • Update on tuberculosis biomarkers: From correlates of risk, to correlates of active disease and of cure from disease
  • Epidemiological, clinical and mechanistic perspectives of tuberculosis in older people
  • Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment
  • Where is tuberculosis transmission happening? Insights from the literature, new tools to study transmission and implications for the elimination of tuberculosis
  • Implementing the End TB Strategy in the Western Pacific Region: Translating vision into reality
  • Latent tuberculosis infection: Opportunities and challenges
  • New drugs and regimens for tuberculosis
  • Drug resistance mechanisms and drug susceptibility testing for tuberculosis
  • Applying new tools to control tuberculosis

Inside Respirology

Vol. 24 Issue 4

EDITORIALS
294Ambulatory oxygen delivery – an answer: But what is the question?
Christine F McDonald FRACP, PhD
10.1111/resp.13505
296CPAP treatment for asthma? A question worth pursuing further
Garun S Hamilton MBBS, FRACP, PhD; Gillian M Nixon MBBS, FRACP, PhD
10.1111/resp.13473
298Is there a common pattern in physical activity levels comparing diverse chronic airway diseases?
Elena Gimeno-Santos PT, Psych, PhD
10.1111/resp.13468
300Lumpers versus splitters: What to do with suspected idiopathic pulmonary fibrosis?
Christopher J Ryerson MD FRCPC
10.1111/resp.13442
302Treating moderate – severe obstructive sleep apnoea for cardiovascular health: Is what stake the stakeholder holds important?
Craig L Phillips PhD; Ronald R Grunstein MBBS MD PhD FRACP
10.1111/resp.13467
COMMENTARY
304Time to FOCUS on oral corticosteroid stewardship in asthma management
Claire N McBrien MBBS, MRCP; Andrew Menzies-Gow BSc, MBBS, PhD, FRCP
10.1111/resp.13494
INVITED REVIEW SERIES
Non-Invasive Ventilation
306Non-invasive ventilation: Inspiring clinical practice
Amanda Piper BAppSc, MEd, PhD; Chung-Ming Chu MD, MSc, FRCP, FCCP
10.1111/resp.13449
308Benefits of non-invasive ventilation in acute hypercapnic respiratory failure
Vittoria Comellini, Angela Maria Grazia Pacilli, Stefano Nava
10.1111/resp.13469
318High-intensity non-invasive ventilation in stable hypercapnic COPD: Evidence of efficacy and practical advice
Sietske van der Leest, Marieke L Duiverman
10.1111/resp.13450
SYSTEMATIC REVIEW
329Comparison of continuous flow versus demand oxygen delivery systems in patients with COPD: A systematic review and meta-analysis
Rainer Gloeckl, Christian Osadnik, Lisa Bies, Daniela Leitl, Andreas-Rembert Koczulla, Klaus Kenn
10.1111/resp.13457
ORIGINAL ARTICLES
Asthma and Allergy
338Effect of CPAP on airway reactivity and airway inflammation in children with moderate – severe asthma
Eduardo Praca, Hasnaa Jalou, Nadia Krupp, Angela Delecaris, Joseph Hatch, James Slaven, Susan J Gunst, Robert S Tepper
10.1111/resp.13441

We compared 4 weeks of nocturnal continuous positive airway pressure (CPAP) versus sham to suppress airway reactivity and inflammation in children with moderate – severe asthma. There were no significant differences between treatments. The treatment effect in children with moderate – severe asthma was smaller than previously reported in adults with mild well-controlled asthma.

Critical Care
345Angiopoietin-2 as a predictor of acute kidney injury in critically ill patients and association with ARDS
Camila Barbosa, Araújo Fernanda Macedo de Oliveira Neves, Daniele Ferreira de Freitas, Bianca Fernandes Távora Arruda, Leonardo José Monteiro de Macêdo Filho, Vivian Brito Salles, Gdayllon Cavalcante Meneses, Alice Maria Costa Martins, Alexandre Braga Libório
10.1111/resp.13464

Angiopoietin-2 (AGPT2) is a known acute respiratory distress syndrome (ARDS) biomarker and its use has been recently proposed for acute kidney injury (AKI). We demonstrated that AGPT2 is associated with AKI only in patients with or developing ARDS. Adding AGPT2 to a clinical model results in significant improvement in the capacity to predict severe AKI in patients with ARDS.

COPD
352Physical activity associates with disease characteristics of severe asthma, bronchiectasis and COPD
Laura Cordova-Rivera, Peter G Gibson, Paul A Gardiner, Vanessa M McDonald
10.1111/resp.13428

This is the first study characterizing and comparing the prevalence of physical activity (PA) between a severe asthma, bronchiectasis, chronic obstructive pulmonary disease (COPD) and a control population; and in testing the associations of key treatable and shared disease characteristics with the level of PA in obstructive airway diseases.

Interstitial Lung Disease
361
Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
Helen E Jo, Ian Glaspole, Nicole Goh, Peter M A Hopkins, Yuben Moodley, Paul N Reynolds, Sally Chapman, Eugene Haydn Walters, Christopher Zappala, Heather Allan, Sacha Macansh, Christopher Grainge, Gregory J Keir, Andrew Hayen, Douglas Henderson, Sonja Klebe, Stefan B Heinze, Anne Miller, Hannah C Rouse, Edwina Duhig, Wendy A Cooper, Annabelle M Mahar, Samantha Ellis, Samuel R McCormack, Bernard Ng, David B Godbolt, Tamera J Corte
10.1111/resp.13427

In clinical practice, physicians may assign a diagnosis of idiopathic pulmonary fibrosis (IPF) in patients who are sufficiently similar in their presentation to IPF but who do not strictly fulfil IPF diagnostic criteria. Our study shows that these patients demonstrate identical disease progression and survival to those who fulfil diagnostic criteria.

Interventional Pulmonology
369Radiofrequency spectral analysis of EBUS for peripheral pulmonary lesions
Kei Morikawa, Noriaki Kurimoto, Takeo Inoue, Teruomi Miyazawa, Masamichi Mineshita
10.1111/resp.13443

Endobronchial ultrasonography (EBUS) is widely used for its high diagnostic rate. This is the first report to investigate the quantitative assessment of EBUS radiofrequency (RF) for peripheral pulmonary lesions. RF analysis might be capable of distinguishing pathological heterogeneity of the lesion better than distinguishing benign and malignant, which can contain various pathological subtypes.

Sleep and Ventilation
376
A consensus opinion amongst stakeholders as to benefits of obstructive sleep apnoea treatment for cardiovascular health
Shane A Landry, Siobhan Banks, Peter A Cistulli, Garun S Hamilton, Laure Héraud, Kristina Kairaitis, Steven Lubke, Sutapa Mukherjee, Teanau Roebuck, Joesph Soda, Darren Umbers, Shantha M W Rajaratnam, Darren Mansfield
10.1111/resp.13413

Commissioned by the Australasian Sleep Association and the Sleep Health Foundation, this statement draws on a panel composed of key sleep medicine stakeholders, including clinicians, researchers, technologists, as well as industry and community groups, to provide consensus of opinion as to the cardiovascular benefits of treating moderate – severe obstructive sleep apnoea.

CONTEMPORARY CONCISE REVIEW
382Contemporary Concise Review 2018: Bronchiectasis
Anne B Chang, Keith Grimwood
10.1111/resp.13502
LETTER FROM ASIA-PACIFIC AND BEYOND
390Letter from South Africa
Charles Feldman MB BCh, DSc, PhD
10.1111/resp.13477
CORRESPONDENCES
392Infection risks for patients from healthcare workers with cystic fibrosis
Mark Thomas MBChB, MD, FRACP; Warwick Bagg MBBCh, MD, FRACP; John Kolbe MBBS, FRACP
10.1111/resp.13487
393Infection risks for patients from healthcare workers with cystic fibrosis - Reply
Scott C Bell MBBS, FRACP, MD; Rhonda L Stuart MBBS, FRACP, PhD
10.1111/resp.13489

Inside Respirology Case Reports

The following cases have been selected for inclusion in the new May 2019 Respirology Case Reports, Volume 07 Issue 4

Case Reports

Organizing pneumonia co-existing with carcinoid tumour: complete resolution with bronchoscopic tumour resection
Divyansh Bajaj, Nevins Todd, Rydhwana Hossain, Karan Mahajan, Whitney Burrows, Ashutosh Sachdeva
DOI: 10.1002/rcr2.409

We report an unusual case of organizing pneumonia occurring as a consequence of obstruction due to a carcinoid tumour and its complete resolution by bronchoscopic relief of obstruction without the need for steroid therapy.

Persistent focal pulmonary opacity elucidated by transbronchial cryobiopsy: a case for larger biopsies
Jasleen Kaur Pannu, Otis Bryant Rickman, Robert James Lentz, Joyce Evelyn Johnson, Fabien Maldonado
DOI: 10.1002/rcr2.410

Persistent pulmonary opacities associated with respiratory symptoms that progress despite medical treatment present a diagnostic dilemma for pulmonologists. We describe the case of a 37-year-old woman presenting with progressive fatigue, shortness of breath, and weight loss over six months with a progressively worsening right basilar infiltrate on chest imaging in spite of antibacterial therapy. Transbronchial cryobiopsy was used to establish the diagnosis after a bronchoscopy with traditional forceps biopsies was non-diagnostic. This case demonstrates the value of cryobiopsy as a second-line strategy for pulmonary infiltrates when aetiology remains unclear after less invasive testing.

Effectiveness of pulmonary vasodilators on pulmonary hypertension associated with POEMS syndrome
Kana Ohashi, Rintaro Nishimura, Shunsuke Sugimoto, Seiichiro Sakao, Nobuhiro Tanabe, Koichiro Tatsumi
DOI: 10.1002/rcr2.411

Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is a rare plasma cell disease. Patients with POEMS syndrome are considered to be at a high risk of developing pulmonary hypertension (PH). Here, we report the effectiveness of the vasodilators, sildenafil and macitentan, in a patient with PH associated with POEMS.

Small cell lung cancer and interstitial pneumonia associated with anti-transcriptional intermediary factor-1γ-positive dermatomyositis
Toshio Kato, Satoru Ito, Toyonori Tsuzuki, Daisuke Watanabe, Akihito Kubo, Etsuro Yamaguchi
DOI: 10.1002/rcr2.412

Antibodies to transcriptional intermediary factor-1γ (TIF-1γ) are strongly associated with malignancy in patients with dermatomyositis. Anti-TIF-1γ antibodies are a relatively low risk for interstitial lung disease. We report the case of a 68-year-old female with small cell lung cancer and interstitial pneumonia who was diagnosed first with dermatomyositis positive for serum anti-TIF-1γ antibodies.

Management of skin sarcoidosis with minocycline monotherapy
Shinichi Sasaki, Motoyasu Kato, Kota Nakamura, Yukiko Namba, Osamu Nagashima, Kazuhisa Takahashi
DOI: 10.1002/rcr2.413

After approximately 1 year of the minocycline monotherapy, nearly all skin sarcoidosis lesions resolved with only light residual scars, despite the poor efficacy of the monotherapy for pulmonary sarcoidosis. Minocycline monotherapy appears to be an effective treatment modality for skin sarcoidosis.

A rare case of lymphadenitis and pulmonary disease caused by Mycobacterium paraffinicum
Pei Sze Carmen Tan, Ruad Perera
DOI: 10.1002/rcr2.414

With over 150 species, non-tuberculous mycobacteria are increasingly recognized to be important human pathogens that pose diagnostic and management challenges. We report a rare case of cervical lymphadenitis and pulmonary disease caused by Mycobacterium paraffinicum.

Unusual presentation of Castleman's disease mimicking lung cancer
Ming-Tsung Chen, Shih-Chun Lee, Chun-Chi Lu, Chen-Liang Tsai
DOI: 10.1002/rcr2.416

The most frequent presentation of Castleman's disease (CD) is a solitary mediastinal mass. We reported a patient with a history of heavy smoking with particular image features of CD, which presented as mediastinal lymphadenopathy and peribronchovascular interstitial thickening mimicking lung cancer or sarcoidosis initially.

Clinical Images

Flexible bronchoscopy and cryoextraction for critical airway obstruction caused by an endobronchial angioleiomyoma
Sumit Chatterji, Efrat Ofek, Tiberiu Shulimzon
DOI: 10.1002/rcr2.415

Rare endobronchial angioleiomyoma causes central airway obstruction and respiratory failure. Clinical management includes flexible bronchoscopy and successful cryoextraction of tumour.

Regional society news

The spotlight this month is on

HONG KONG

Each month we share details of activities of a particular country, region or society.

If you would like the spotlight to be on your country, region or society next month, contact the Bulletin Coordinator or APSR Secretariat.

Hong Kong Thoracic Society (HKTS)

Other notable society events and news:

Japan

Japanese Respiratory Society

The 59th Annual Meeting of the Japanese Respiratory Society will be held on 12-14 April 2019 at the Tokyo International Forum.

The Meeting's president will be Prof. Koichiro Tatsumi (Department of Respirology, Chiba University)

Details: www.jrs.or.jp/english/?content_id=27

We are delighted to announce three APSR Travel Awardees for this Meeting:

  • Dr Rachel Ee Lin Foong
    NHMRC Early Career Fellow, Telethon Kids Institute, Perth, Australia

    Dr Foong will present "Ability of the Lung Clearance Index to Monitor the Progression of Early Lung Disease in Children with Cystic Fibrosis"

  • Dr Ralph Elvi M Villalobos
    Philippine College of Chest Physicians

    Dr Villalobos will present "Safety and Efficacy of Beta Blockers in COPD: A review"

  • Dr Ching-Yao Yang
    Graduate school of Pathology, National Taiwan University

    Dr Yang will present "The Impact of Pre-Treatment PD-L 1 on Clinical Outcomes of Lung Adenocarcinoma Patients with EGFR mutations Receiving Targeted Therapies"

Extra-regional societies

Panama

The 12th Congress of the Asociación Latinoamericana del Tórax (ALAT) will take place at the ATLAPA Convention Center in Panama City 3–6 July 2019.

By the kind invitation of Congress Scientific Committee, Dr Kwun Fong (APSR President) and Dr David C L Lam (Immediate Past Chair of the APSR Education Committee) will be the APSR's representative speakers at the Congress.

The symposium APSR–ALAT–WHO essential medicine for respiratory illnesses: unique window of opportunity to address global equity, will be held on 08:00 – 10:00 on 6 July in La Huaca Room of the conference centre:

  • "Access of essential medicines in smoking cessation"
    Dr David C L Lam
  • "Access of essential drugs in COPD: LAMA"
    Dr Rogelio Perez Padilla
  • "Access of essential medicines in lung cancer"
    Dr Kwun Fong
  • "Access of essential medicines in Asthma: LABA / ICS"
    Dr Federico Daniel Colodenco
  • Q&A

The APSR is looking forward to collaborating further with the ALAT in the future.

Health news

Do the Do-Re-Me

Most adults probably find this YouTube animation annoying, but children and those who like rap "music" might appreciate it.

However, both children and adults could enjoy the benefits outlined in the following article from Wales, UK. It's not news, but is a worthwhile reminder of an enjoyable treatment for lung patients:

Sing for lung health

A singing group is helping people living with chronic respiratory conditions to cope when breathlessness restricts their lives.

The Bangor Singing for Lung Health group acts as therapy for patients who have COPD, asthma, bronchiectasis and pulmonary fibrosis. Nurse Olwen Davies said singing helped with breathing techniques. Betsi Cadwaladr University Health Board has made the sessions accessible to all patients who need them.

Ms Davies, a respiratory nurse, said patients attending the sessions - which started in May 2016 - were "doing far more than 'just singing'. It provides a safe, friendly environment to meet, relax, interact, focus and engage with others who have similar health problems," she said. "Many who attend the sessions have said they have helped with their self-management and breathing techniques."

Gillian Saxon, 63, from Llangefni, Anglesey, who has bronchiectasis, said it was "amazing" how her breathing had improved since joining the group. "With my condition it is a real struggle to breathe which impacts on my sleeping pattern," she said. "Coming to this group has made me realise I am not on my own and I get the support that I need."

Pat Roberts, 71, from Bangor, Gwynedd, who also has bronchiectasis, added: "I really was housebound before coming to this group. "It was a struggle to go anywhere as I found it so hard to catch my breath but since coming to the sessions I get out and about a lot more. I can even sing in church better now. It has brought a lot of pleasure back into my life."

The sessions are run by singing performer and teacher Jenny Pearson, who works for the Welsh National Opera and Boys Aloud, and managed by Betsi Cadwaladr University Health Board's professional lead of art therapies, Christine Eastwood, who piloted the first trial in 2013.


An alternative if you cannot join a group!

She said: "Each session is a composition of postural work, relaxation, singing related breathing exercises, simple vocal exercises and singing of an enjoyable and broad song repertoire. The sessions not only offer enjoyment and fun but they also reduce stress, counteracting anxiety and depression. They also provide individuals with gentle physical exercise and physical relaxation and they can release any physical tension."

(Extracted from www.bbc.com/news/uk-wales-45726331
16 March 2019)

26 March was World TB Day

The Forum of International Respiratory Societies (FIRS) recently issued a press release on TB:

Acceleration of UN High-Level Meeting Commitments on TB Focus of International Respiratory Societies

(Click any image to enlarge)





On World TB Day, the Forum of International Respiratory Societies (FIRS) urges governments to leverage the success of the first-ever United Nation (UN) High-Level Meeting (HLM) on the fight against tuberculosis (TB), held in 2018. The meeting produced a UN political declaration on TB and endorsement at the highest level to take the necessary steps to end the TB epidemic.

TB is preventable and curable, yet it remains the world's most common infectious disease killer. The World Health Organization (WHO) estimates that 10 million people fell ill from TB in 2017 and 1.6 million people died. Only 64 percent of the estimated 10 million global TB cases were actually diagnosed and notified. In 2017, approximately 558,000 people developed TB that was resistant to rifampicin (RR-TB), and of these, 82 percent had multidrug-resistant TB (MDR-TB). Only one in four people who needed treatment for MDR/RR-TB in 2017 actually received it.

For the first time the High-Level Meeting brought together heads of state to give the leadership that is urgently needed to address this terrible disease. This unique opportunity and momentum must not be lost.

FIRS is calling on leaders to follow through on the commitments they have made, including to:

  • Successfully treat 40 million people for TB, including 3.5 million children and 1.5 million people with drug-resistant TB.
  • Provide TB preventive therapy to 30 million people, including four million children under the age of five.
  • Include child TB in the child survival agenda and provide family-based TB care.
  • Advance all areas of innovation needed to deliver new tools for TB prevention, diagnosis and treatment.
  • Support a human rights-based approach to global TB.
  • Mobilise U.S. $13 billion annually for TB care, and U.S. $2 billion annually for TB research and development.

FIRS urges the TB community to hold leaders accountable for their commitments, and to push governments to support the changes needed to realise the UN Sustainable Development Goal of ending the TB epidemic by 2030.

Dean E Schraufnagel, MD, executive director, FIRS, said: "If we are to truly see an end to TB, the world's most common and deadly infectious disease, governments must commit to scale up of research, funding, human rights and accountability. It is our job as the TB community to strive for the commitments we've seen from our leaders to become action and not just promises."

By adopting the UN political declaration on TB, national leaders have said they recognise TB as a threat they are committed to eradicating. They have agreed to specific actions. The day to begin implementing this new agenda begins now.

Notes: All quoted TB statistics are from the Global Tuberculosis Report 2018, The World Health Organization

For more information about FIRS please contact Lisa Roscoe lisa.roscoe@firsnet.org.

About FIRS

The Forum of International Respiratory Societies (FIRS) is an organisation comprised of the world's leading international respiratory societies working together to improve lung health globally: American College of Chest Physicians (CHEST), American Thoracic Society (ATS), Asian Pacific Society of Respirology (APSR), Asociación Latino Americana De Tórax (ALAT), European Respiratory Society (ERS), International Union Against Tuberculosis and Lung Diseases (The Union), Pan African Thoracic Society (PATS), Global Initiative for Asthma (GINA), and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

The goal of FIRS is to unify and enhance efforts to improve lung health through the combined work of its more than 70,000 members globally.

For more information about FIRS please contact Lisa Roscoe lisa.roscoe@firsnet.org.

Education

Webinars from the Thoracic Society of Australia and New Zealand (TSANZ)

The TSANZ are now streaming the following webinars for public viewing:

  • The Human Respiratory Virome
    by Prof. Allan Glanville
    recorded 29 August 2018
  • NIV Therapy – viewed via a community lens
    by Sally Powell
    recorded 6 August 2018
  • Accelerated Silicosis, kitchen benchtops and the emerging epidemic
    by Dr Ryan Hoy & Dr Graeme Edwards
    recorded 11 October 2018
  • Research Techniques To Study Respiratory Diseases
    by Prof. Phil Hansbro
    recorded 11 October 2018
  • What's in a cough? Implications for the care of people with flu and MROs
    by Prof. Scott Bell
    recorded 27 November 2018
  • Primary Ciliary Dyskinesia: Common symptoms from an uncommon condition
    by A/Prof. Phil Robinson
    recorded 11 December 2018
  • The Impact of Climate Change on Respiratory Health
    by Professor Hubertus Jersmann
    recorded 14 February 2019
  • What we have learned about children who present to hospital with acute wheeze
    by Dr Ingrid Laing
    recorded 26 February 2019
  • How respiratory specialists can best assist smoking patients to quit
    by A/Prof. Renee Bittoun
    recorded 8 March 2019

To access any of the above, click www.thoracic.org.au/events/category/past-tsanz-webinars-on-demand-recordings. Note that for non-TSANZ members, some of the above webinars require payment of a A$10 (plus A$1 GST) pay-as-you-view fee to the TSANZ.

APSR Membership

Donations received

has kindly sent his donation towards the Society's goals, as outlined at apsresp.org/members/donors.php.

The APSR is profoundly grateful for his generosity.

New Fellows of the APSR

Congratulations to the following members who have recently become APSR Fellows.

  • Dr David Alvianto FAPSR (Indonesia)
  • Dr Iin Chozin FAPSR (Indonesia)
  • Dr Jakeer Hussain Shaik FAPSR (India)
  • Dr Anung Sri Handayani FAPSR (Indonesia)
  • Dr Andi Wijayanto FAPSR (Indonesia)

New assembly members

A warm welcome to the following members who have recently joined APSR assemblies. They will undoubtedly enjoy working with and networking with their assembly colleagues.

Assemblies
David Alvianto
(Indonesia)
Bronchoscopy and Interventional Techniques
Critical Care Medicine
Tuberculosis
Nadeem Arshad
(India)
Clinical Respiratory Medicine
Tuberculosis
COPD
Iin Chozin
(Indonesia)
Paediatric Lung Disease
Clinical Respiratory Medicine
Clinical Allergy & Immunology
Kean Cheang Khoo
(Australia)
Clinical Respiratory Medicine
Respiratory Infections (non-tuberculous)
Interstitial Lung Disease
Prabhu Prasad Nidagatta Channappa
(India)
Bronchoscopy and Interventional Techniques
Respiratory Neurobiology and Sleep
Lung Cancer
Raghavendra Reddy Pedditi
(India)
Bronchoscopy and Interventional Techniques
Clinical Respiratory Medicine
Respiratory Neurobiology and Sleep
Jaka Pradipta
(Indonesia)
Bronchoscopy and Interventional Techniques
Lung Cancer
Tuberculosis
Inderpaul Singh Sehgal
(India)
Critical Care Medicine
Bronchoscopy and Interventional Techniques
Respiratory Infections (non-tuberculous)
Jakeer Hussain Shaik
(India)
Respiratory Infections (non-tuberculous)
Asthma
Critical Care Medicine
Dalveer Singh
(Australia)
Clinical Respiratory Medicine
Lung Cancer
Interstitial Lung Disease
Anung Sri Handayani
(Indonesia)
Critical Care Medicine
Bronchoscopy and Interventional Techniques
Lung Cancer
Ayuningtyas Setyoreni Sudijono
(Indonesia)
Lung Cancer
Tuberculosis
Bronchoscopy and Interventional Techniques
Xiaoxiao Tang
(China)
Interstitial Lung Disease
COPD
Cell and Molecular Biology
Andi Wijayanto
(Indonesia)
COPD
Tuberculosis
Asthma
Wai-Shiu Fred Wong
(Singapore)
Cell and Molecular Biology
Asthma
COPD

Future Pulmonology Events

Here are the main respiratory events in Asia-Pacific region for the next few months. You can see our full listing on the APSR Calendar.

  • 59th Annual Meeting of the Japanese Respiratory Society
    12-14 April 2019, Tokyo, Japan
    (Details)
  • 127th Conference of the Korean Academy of Tuberculosis and Respiratory Diseases (KATRD)
    13 April 2019, Gangwon-Do, Korea
    (Details)
  • China-Japan-Korea Conference of Occupational Health
    22–24 April 2019, Nanjing, China
    (Details)
  • 7th Conference of the International Union Against Tuberculosis and Lung Disease, Asia-Pacific Region 2019
    23-26 April 2019, Manila, Philippines
    (Details)
  • World Asthma Day
    7 May 2019, Worldwide
    (Details)
  • Asthma & COPD Outpatient Care Unit (ACOCU) Network Day
    12 May 2019, Ho Chi Minh City, Vietnam
    (Details)
  • 92nd annual meeting of Japan Society for Occupational Health
    22–25 May 2019, Nagoya, Japan
    (Details)
  • World No Tobacco Day
    31 May 2019, Worldwide
    (Details)
  • MTS Annual Congress 2019
    18-21 July 2019, Kuala Lumpur, Malaysia
    (Details)
  • Annual Scientific Congress of Ho Chi Minh City Society of Asthma, Allergy & Clinical Immunology
    21 July 2019, Ho Chi Minh City, Vietnam
    (Details)
  • 16th Annual Meeting: Work Conference of the Indonesian Society of Respirology (ISR)
    11-14 September 2019, Surakarta, Central Java, Indonesia
    (Details)

For more pulmonology events, see apsresp.org/calendar.html
(These events are for information only and APSR endorsement should not be assumed.)

Contact

If you have news or announcements that may be of interest to other APSR members, please send details to Bulletin Coordinator Dr Arata Azuma (a-azuma@nms.ac.jp) or APSR Bulletin (bulletin@apsresp.org).


Click here to see previous issues of the Bulletin
If you prefer not to receive further APSR Bulletins, click unsubscribe
Comments: bulletin@apsresp.org or APSRinfo@theapsr.org
© Asian Pacific Society of Respirology